Sign in
4

Changes in Ownership

Polaryx Therapeutics, Inc. Filed Acc 0001213900-26-018845

Chief Financial Officer bought 2,867 shares at $2.79 ($7,991)

From the SEC's structured data for this filing

Trades in this filing

Landis G. Michael · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Purchase : show line 1 in the form +2,867 $2.79 $7,991 228,225 D
Open-market purchases · 2,867 sh · avg $2.79 · $7,991
Loading xslF345X05/ownership.xml…